Treatment failure due to methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin

被引：60
|
作者：
Ward, PB
Johnson, PDR
Grabsch, EA
Mayall, BC
Grayson, ML
机构：
[1] Austin & Repatriat Med Ctr, Dept Microbiol, Heidelberg, Vic 3084, Australia
[2] Austin & Repatriat Med Ctr, Dept Infect Dis, Heidelberg, Vic 3084, Australia
来源：
MEDICAL JOURNAL OF AUSTRALIA | 2001年 / 175卷 / 09期
关键词：
D O I：
10.5694/j.1326-5377.2001.tb143681.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
We report the first instance in Australia of treatment failure due to a strain of methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin - heteroresistant vancomycin-intermediate S. aureus (hVISA). The infection occurred in a 41-year-old man with multiple risk factors. No transmission of the organism to other patients or the environment was detected. This case may herald the beginning of a new phase of staphylococcal resistance in Australia.
引用
收藏
页码：480 / +
页数：5
相关论文
共 50 条
  • [31] Linezolid treatment of prosthetic hip infections due to methicillin-resistant Staphylococcus aureus (MRSA)
    Matteo Bassetti
    Antonio Di Biagio
    Giovanni Cenderello
    Valerio Del Bono
    Augusto Palermo
    Luigi Molfetta
    Francesco Pipino
    Dante Bassetti
    Journal of Orthopaedics and Traumatology, 2000, 1 (3) : 147 - 150
  • [32] Reduced Vancomycin Susceptibility, MRSA and Treatment Failure in Pediatric Staphylococcus aureus Bloodstream Infections
    Canty, Ethan
    Carnahan, Benjamin
    Curley, Tara
    Anususinha, Emily
    Hamdy, Rana F.
    Ericson, Jessica E.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2021, 40 (05) : 429 - 433
  • [33] External ocular infections due to methicillin-resistant Staphylococcus aureus (MRSA)
    V A Shanmuganathan
    M Armstrong
    A Buller
    A B Tullo
    Eye, 2005, 19 : 284 - 291
  • [34] External ocular infections due to methicillin-resistant Staphylococcus aureus (MRSA)
    Shanmuganathan, VA
    Armstrong, M
    Buller, A
    Tullo, AB
    EYE, 2005, 19 (03) : 284 - 291
  • [35] Reduced susceptibility to teicoplanin in a methicillin-resistant strain of Staphylococcus aureus
    Fitch, L
    Johnson, AP
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (05) : 578 - 578
  • [36] Prior Vancomycin Use Is a Risk Factor for Reduced Vancomycin Susceptibility in Methicillin-Susceptible but Not Methicillin-Resistant Staphylococcus aureus Bacteremia
    Mascitti, Kara B.
    Edelstein, Paul H.
    Fishman, Neil O.
    Morales, Knashawn H.
    Baltus, Andrew J.
    Lautenbach, Ebbing
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2012, 33 (02): : 160 - 166
  • [37] Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections
    Micek, Scott T.
    CLINICAL INFECTIOUS DISEASES, 2007, 45 : S184 - S190
  • [38] The first infection due to vancomycin-resistant methicillin-resistant Staphylococcus aureus?
    Marin, JEN
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1996, 7 (04) : 293 - 293
  • [39] Vancomycin Heteroresistance and Methicillin-Resistant Staphylococcus aureus
    Deresinski, Stan
    JOURNAL OF INFECTIOUS DISEASES, 2009, 199 (05): : 605 - 609
  • [40] Accuracy of Commercial Susceptibility Testing Method for Measuring Vancomycin MIC Against Methicillin-Resistant Staphylococcus aureus (MRSA)
    Toyokawa, Masahiro
    Francisco, Mark
    Nishi, Isao
    Sunada, Atsuko
    Ueda, Akiko
    Sakata, Tomomi
    Kimura, Keigo
    Inoue, Yoriko
    Asari, Seishi
    Tomono, Kazunori
    LABMEDICINE, 2011, 42 (08): : 473 - 477
12345